The Global Breast Retractors Market size is expected to reach $473.6 Million by 2030, rising at a market growth of 4.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,739.5 thousand units, experiencing a growth of 4.9% (2019-2022).
Modern surgical methods and technology have made breast augmentation safer and more accessible. In addition, surgical innovations such as cohesive silicone gel implants and improved incision techniques have enabled superior outcomes and shorter recovery times. Therefore, the breast augmentation segment would capture approximately 30% share of the market by 2030. Some of the factors impacting the market are rising incidence of breast cancer, advancements in surgical techniques, and stringent regulatory requirements.
The increasing prevalence of breast cancer globally is a significant driver of the market. Breast retractors are vital in breast cancer surgeries, including mastectomies and lumpectomies. According to the World Health Organization (WHO), in 2020, there were 2.3 million new breast cancer cases and 685,000 fatalities globally. The most frequent cancer globally is breast cancer, affecting 7.8 million people alive as of the end of 2020. In every country, breast cancer affects women of any age after puberty, but the incidence rate increases with age. The rising incidence of breast cancer underscores the importance of breast retractors in managing this disease. These retractors not only aid in the surgical removal of cancerous tissue but also help preserve surrounding healthy tissue. Additionally, as surgical techniques advance, training and education for healthcare professionals are crucial. Surgeons need to be proficient in using advanced breast retractors to maximize their benefits. This emphasis on training contributes to the adoption of these devices. Some advanced breast retractors come with integrated technology, such as LED lighting and camera systems. These technological features enhance the surgeon's ability to perform complex surgical procedures and achieve precise outcomes. Advancements in surgical techniques have led to more specialized breast retractors tailored to modern surgical approaches' needs. These advancements are instrumental in improving the precision and safety of breast procedures while enhancing the overall patient experience. Advances in surgical techniques have a significant impact on the market.
However, Regulatory requirements can vary substantially from country to country. Adapting products to meet different global standards can be challenging and costly. The costs associated with regulatory compliance are often passed on to consumers, making medical devices, including breast retractors, more expensive. Maintaining stringent quality control standards and conducting rigorous testing to meet regulatory requirements can increase the overall production cost of breast retractors. The fear of regulatory hurdles can discourage some manufacturers from investing in innovative technologies and designs, limiting the pace of technological advancements in the field. The pandemic disrupted global supply chains, causing delays in the production and distribution of medical devices, including breast retractors. Manufacturers faced challenges in sourcing raw materials components and maintaining production schedules, impacting product availability. As a result of the pandemic, numerous healthcare facilities postponed or canceled elective procedures such as breast augmentation, breast reduction, and cosmetic breast surgery. This reduction in the number of surgeries led to a decreased demand for breast retractors during the initial stages of the pandemic.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Integra LifeSciences Holdings Corporation, OBP Medical Corporation, Gulmaher Surgico, Jalal Surgical, Hayden Medical Inc., Thompson Surgical Instruments Inc., CooperSurgical, Inc. (The Cooper Companies, Inc.), and Surtex Instruments Ltd.
Modern surgical methods and technology have made breast augmentation safer and more accessible. In addition, surgical innovations such as cohesive silicone gel implants and improved incision techniques have enabled superior outcomes and shorter recovery times. Therefore, the breast augmentation segment would capture approximately 30% share of the market by 2030. Some of the factors impacting the market are rising incidence of breast cancer, advancements in surgical techniques, and stringent regulatory requirements.
The increasing prevalence of breast cancer globally is a significant driver of the market. Breast retractors are vital in breast cancer surgeries, including mastectomies and lumpectomies. According to the World Health Organization (WHO), in 2020, there were 2.3 million new breast cancer cases and 685,000 fatalities globally. The most frequent cancer globally is breast cancer, affecting 7.8 million people alive as of the end of 2020. In every country, breast cancer affects women of any age after puberty, but the incidence rate increases with age. The rising incidence of breast cancer underscores the importance of breast retractors in managing this disease. These retractors not only aid in the surgical removal of cancerous tissue but also help preserve surrounding healthy tissue. Additionally, as surgical techniques advance, training and education for healthcare professionals are crucial. Surgeons need to be proficient in using advanced breast retractors to maximize their benefits. This emphasis on training contributes to the adoption of these devices. Some advanced breast retractors come with integrated technology, such as LED lighting and camera systems. These technological features enhance the surgeon's ability to perform complex surgical procedures and achieve precise outcomes. Advancements in surgical techniques have led to more specialized breast retractors tailored to modern surgical approaches' needs. These advancements are instrumental in improving the precision and safety of breast procedures while enhancing the overall patient experience. Advances in surgical techniques have a significant impact on the market.
However, Regulatory requirements can vary substantially from country to country. Adapting products to meet different global standards can be challenging and costly. The costs associated with regulatory compliance are often passed on to consumers, making medical devices, including breast retractors, more expensive. Maintaining stringent quality control standards and conducting rigorous testing to meet regulatory requirements can increase the overall production cost of breast retractors. The fear of regulatory hurdles can discourage some manufacturers from investing in innovative technologies and designs, limiting the pace of technological advancements in the field. The pandemic disrupted global supply chains, causing delays in the production and distribution of medical devices, including breast retractors. Manufacturers faced challenges in sourcing raw materials components and maintaining production schedules, impacting product availability. As a result of the pandemic, numerous healthcare facilities postponed or canceled elective procedures such as breast augmentation, breast reduction, and cosmetic breast surgery. This reduction in the number of surgeries led to a decreased demand for breast retractors during the initial stages of the pandemic.
Application Outlook
On the basis of application, the market is divided into mastectomy, breast reconstruction, breast augmentation, lumpectomy, and breast reduction. The lumpectomy segment procured a promising growth rate in the market in 2022. Recent advancements in breast cancer treatment, such as chemotherapy, targeted drugs, and radiation therapy, have made it possible to successfully treat smaller tumors with lumpectomy. This has increased the number of lumpectomy procedures. Moreover, as breast-conserving surgery preserves a more natural breast appearance than mastectomy, an increasing number of women are opting for these procedures. In addition, retractors and other minimally invasive surgical apparatus have made lumpectomy treatments more accessible and less invasive. These techniques frequently result in smaller incisions and more rapid recoveries.End-use Outlook
By end-use, the market is segmented into hospitals, clinics, and ambulatory surgical centers. In 2022, the hospitals segment registered the maximum revenue share in the market. Skilled surgical teams in hospitals regularly perform assisted breast operations in inpatient and outpatient settings. Hospitals' sterile, controlled environments are optimal for breast surgery. These procedures frequently require specialized equipment, such as surgical retractors, to ensure optimal visibility and access to the surgical site. In hospital contexts, surgeons, anesthesiologists, nurses, and other medical specialists collaborate to perform these procedures successfully and safely. Hospitals are also equipped to manage potential complications and provide comprehensive care to breast surgery patients.
Usage Outlook
Based on usage, the market is classified into reusable and disposable. The disposable segment acquired a substantial revenue share in the market in 2022. Hospital settings place a growing emphasis on infection control and reducing the risk of healthcare-associated infections (HAIs). Since disposable retractors are sterile and single-use, they reduce the risk of cross-contamination, making them the best option for procedures where infection is a concern. Disposable breast retractors, which do not require frequent cleansing, sterilization, or maintenance, simplify the surgical procedure. These devices aid surgical teams in saving time and expediting operations.Type Outlook
By type, the market is bifurcated into handheld and self-retaining. The self-retaining segment covered a considerable revenue share in the market in 2022. Self-retaining retractors enable the surgeon to perform the procedure using only one hand. This enhances surgical control and precision in various breast treatments, including breast reconstruction, augmentation, reduction, and breast cancer surgery. Self-retaining retractors are designed to provide the greatest possible surgical site access. To provide a clear view and simple access to the target tissues, surgeons can adjust the retraction angle and position to meet the specific treatment requirements.Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The affected population (those with breast cancer) is growing more knowledgeable about the availability of surgical procedures in the region and the broad acceptance of aesthetic procedures. According to the American Cancer Society, breast cancer is the most frequent cancer among women in the United States. The increase in breast reconstruction surgeries in the region is another reason for boosting interest in surgical breast retractor devices. With the introduction of cutting-edge technologies such as 3D printing and robotics, the market is expanding in this region.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Integra LifeSciences Holdings Corporation, OBP Medical Corporation, Gulmaher Surgico, Jalal Surgical, Hayden Medical Inc., Thompson Surgical Instruments Inc., CooperSurgical, Inc. (The Cooper Companies, Inc.), and Surtex Instruments Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type (Volume, Thousand Units, USD Thousands, 2019-2030)- Handheld
- Self-retaining
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Reusable
- Disposable
- Breast Augmentation
- Breast Reconstruction
- Mastectomy
- Breast Reduction
- Lumpectomy
- North America
- US
- Canada
- Mexico
- Rest of North America- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- OBP Medical Corporation
- Gulmaher Surgico
- Jalal Surgical
- Hayden Medical Inc.
- Thompson Surgical Instruments Inc.
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- Surtex Instruments Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Breast Retractors Market by Type
Chapter 5. Global Breast Retractors Market by End-use
Chapter 6. Global Breast Retractors Market by Usage
Chapter 7. Global Breast Retractors Market by Application
Chapter 8. Global Breast Retractors Market by Region
Chapter 9. Company Profiles
Companies Mentioned
- Medtronic PLC
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- OBP Medical Corporation
- Gulmaher Surgico
- Jalal Surgical
- Hayden Medical Inc.
- Thompson Surgical Instruments Inc.
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- Surtex Instruments Ltd.
Methodology
LOADING...
